Pulmonary Embolism (PE) is a life-threatening condition that is a leading cause of morbidity and mortality. PE occurs when there is a disruption to the blood flow in the pulmonary artery, usually from a blood clot formed in the veins and causes severe respiratory dysfunction.
PE is diagnosed with the use of a computed tomography pulmonary angiogram, with the most common treatment for PE being anticoagulants, catheter-based fibrinolysis, systemic fibrinolysis, and surgical pulmonary embolectomy (SPE) can also be used.
Early detection is important as mortality can be reduced with early treatment. However, PE is often difficult to diagnose as the symptoms of PE are similar to a number of other conditions and diseases.
This Research Topic aims to highlight the latest updates in diagnostic and therapeutic strategies aimed at reducing the mortality and morbidity associated with PE. These strategies can include but are not limited to radiological artificial intelligence, new biomarkers or clinical risk model evaluation tools.
Pulmonary Embolism (PE) is a life-threatening condition that is a leading cause of morbidity and mortality. PE occurs when there is a disruption to the blood flow in the pulmonary artery, usually from a blood clot formed in the veins and causes severe respiratory dysfunction.
PE is diagnosed with the use of a computed tomography pulmonary angiogram, with the most common treatment for PE being anticoagulants, catheter-based fibrinolysis, systemic fibrinolysis, and surgical pulmonary embolectomy (SPE) can also be used.
Early detection is important as mortality can be reduced with early treatment. However, PE is often difficult to diagnose as the symptoms of PE are similar to a number of other conditions and diseases.
This Research Topic aims to highlight the latest updates in diagnostic and therapeutic strategies aimed at reducing the mortality and morbidity associated with PE. These strategies can include but are not limited to radiological artificial intelligence, new biomarkers or clinical risk model evaluation tools.